Webster-Clark M - Search Results

1

Core Concepts in Pharmacoepidemiology: New-User Designs.

Her QL, Rouette J, Young JC, Webster-Clark M, Tazare J. Her QL, et al. Among authors: webster clark m. Pharmacoepidemiol Drug Saf. 2024 Dec;33(12):e70048. doi: 10.1002/pds.70048. Pharmacoepidemiol Drug Saf. 2024. PMID: 39586646 Free PMC article. Review.

2

Variable selection when estimating effects in external target populations.

Webster-Clark M, Ross RK, Keil AP, Platt RW. Webster-Clark M, et al. Am J Epidemiol. 2024 Aug 5;193(8):1176-1181. doi: 10.1093/aje/kwae048. Am J Epidemiol. 2024. PMID: 38629587 Free PMC article.

3

Clarifying the causal contrast: An empirical example applying the prevalent new user study design.

Young JC, Webster-Clark M, Shmuel S, Garry EM, Mavros P, Stürmer T, Girman CJ. Young JC, et al. Among authors: webster clark m. Pharmacoepidemiol Drug Saf. 2024 Apr;33(4):e5790. doi: 10.1002/pds.5790. Pharmacoepidemiol Drug Saf. 2024. PMID: 38575389

4

Standardizing to specific target populations in distributed networks and multisite pharmacoepidemiologic studies.

Webster-Clark M, Filion KB, Platt RW. Webster-Clark M, et al. Am J Epidemiol. 2024 Jul 8;193(7):1031-1039. doi: 10.1093/aje/kwae015. Am J Epidemiol. 2024. PMID: 38412261 Free PMC article.

5

Visualizing External Validity: Graphical Displays to Inform the Extension of Treatment Effects from Trials to Clinical Practice.

Lund JL, Webster-Clark MA, Westreich D, Sanoff HK, Robert N, Frytak JR, Boyd M, Shmuel S, Stürmer T, Keil AP. Lund JL, et al. Among authors: webster clark ma. Epidemiology. 2024 Mar 1;35(2):241-251. doi: 10.1097/EDE.0000000000001694. Epub 2023 Jan 30. Epidemiology. 2024. PMID: 38290143 Free PMC article.

6

External validity in distributed data networks.

Webster-Clark M, Toh S, Arnold J, McTigue KM, Carton T, Platt R. Webster-Clark M, et al. Pharmacoepidemiol Drug Saf. 2023 Dec;32(12):1360-1367. doi: 10.1002/pds.5666. Epub 2023 Jul 18. Pharmacoepidemiol Drug Saf. 2023. PMID: 37463756

7

How Choice of Effect Measure Influences Minimally Sufficient Adjustment Sets for External Validity.

Webster-Clark M, Keil AP. Webster-Clark M, et al. Am J Epidemiol. 2023 Jul 7;192(7):1148-1154. doi: 10.1093/aje/kwad041. Am J Epidemiol. 2023. PMID: 36813295

8

Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose.

Webster-Clark M, Keil AP, Robert N, Frytak JR, Boyd M, Stürmer T, Sanoff H, Westreich D, Lund JL. Webster-Clark M, et al. JAMA Oncol. 2022 Oct 13;8(12):1821-4. doi: 10.1001/jamaoncol.2022.4445. Online ahead of print. JAMA Oncol. 2022. PMID: 36227604 Free PMC article.

9

A systematic review of whether COVID-19 randomized controlled trials reported on demographic and clinical characteristics.

Pak J, Lund JL, Keil A, Westreich D, Stürmer T, Wohl D, Farel C, Drummond MB, Webster-Clark M. Pak J, et al. Among authors: webster clark m. Pharmacoepidemiol Drug Saf. 2022 Dec;31(12):1219-1227. doi: 10.1002/pds.5533. Epub 2022 Oct 5. Pharmacoepidemiol Drug Saf. 2022. PMID: 35996832 Free PMC article. Review.

10

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example.

Duchesneau ED, Jackson BE, Webster-Clark M, Lund JL, Reeder-Hayes KE, Nápoles AM, Strassle PD. Duchesneau ED, et al. Among authors: webster clark m. Cancer Epidemiol Biomarkers Prev. 2022 Nov 2;31(11):2079-2086. doi: 10.1158/1055-9965.EPI-22-0495. Cancer Epidemiol Biomarkers Prev. 2022. PMID: 35984990 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters